2025 Europe Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 Europe Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European Antimicrobial Susceptibility Testing (AST) market are bioMérieux S.A. (France), Becton, Dickinson and Company (BD, US), Thermo Fisher Scientific Inc. (US), and Danaher Corporation (US). These companies collectively dominate the market, holding a significant share through their extensive portfolios of AST instruments, consumables, and automated systems tailored to European healthcare and research needs. bioMérieux is a major European player with strong expertise in microbial diagnostics, while BD, Thermo Fisher, and Danaher supply advanced diagnostic technologies and automation systems widely adopted in European hospitals and laboratories.
Market growth in Europe is driven largely by rising antimicrobial resistance and a high prevalence of infectious diseases, fostering demand for accurate, fast AST methods including manual and automated tests. Germany leads Europe in AST market revenue, with key companies leveraging innovations in automation and rapid testing products to meet increasing clinical needs. The collaboration of these four global leaders with European research institutions and healthcare providers fuels ongoing development of new AST solutions critical to managing antimicrobial resistance and improving patient outcomes.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European Antimicrobial Susceptibility Testing (AST) market are bioMérieux S.A. (France), Becton, Dickinson and Company (BD, US), Thermo Fisher Scientific Inc. (US), and Danaher Corporation (US). These companies collectively dominate the market, holding a significant share through their extensive portfolios of AST instruments, consumables, and automated systems tailored to European healthcare and research needs. bioMérieux is a major European player with strong expertise in microbial diagnostics, while BD, Thermo Fisher, and Danaher supply advanced diagnostic technologies and automation systems widely adopted in European hospitals and laboratories.
Market growth in Europe is driven largely by rising antimicrobial resistance and a high prevalence of infectious diseases, fostering demand for accurate, fast AST methods including manual and automated tests. Germany leads Europe in AST market revenue, with key companies leveraging innovations in automation and rapid testing products to meet increasing clinical needs. The collaboration of these four global leaders with European research institutions and healthcare providers fuels ongoing development of new AST solutions critical to managing antimicrobial resistance and improving patient outcomes.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
